Answers are grounded in this paper and cite their sources.
Repaglinide was safe and well tolerated in subjects with varying degrees of renal impairment. Although adjustment of starting doses of repaglinide is not necessary for renal impairment or renal failure, severe impairment may require more care when upward adjustments of dosage are made.
No takes yet. Share an insight, caveat, or question.
Thomas Marbury (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: